Evaluation of a Novel Point-of-Care Blood Myxovirus Resistance Protein A Measurement for the Detection of Viral Infection at the Pediatric Emergency Department
The Journal of Infectious Diseases · 2024
DOI: 10.1093/infdis/jiae367 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift The Journal of Infectious Diseases, 2024. Verfasst von Ruut Piri und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics and Adolescent Medicine, Turku University Hospital and University of Turku. Hauptthemen laut MEDLINE: Myxovirus Resistance Proteins, Emergency Service, Hospital, Virus Diseases, Point-of-Care Systems. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Turku, Foundation for Pediatric Research, Maud Kuistila Memorial Foundation.
Abstract (Originalsprache)
Background
Prompt differentiation of viral from bacterial infections in febrile children is pivotal in reducing antibiotic overuse. Myxovirus resistance protein A (MxA) is a promising viral biomarker.
Methods
We evaluated the accuracy of a point-of-care (POC) measurement for blood MxA level compared to the reference enzyme immunoassay in 228 febrile children aged between 4 weeks and 16 years, enrolled primarily at the emergency department (ED). Furthermore, we analyzed the ability of MxA to differentiate viral from bacterial infections.
Results
The mean difference between POC and reference MxA level was −76 µg/L (95% limits of agreement from −409 to 257 µg/L). Using a cutoff of 200 µg/L, POC results were uniform with the reference assay in 199 (87.3%) children. In ED-collected samples, the median POC MxA level was 571 (interquartile range [IQR], 240–955) µg/L in children with viral infections, 555 (IQR, 103–889) µg/L in children with viral-bacterial coinfections, and 25 (IQR, 25–54) µg/L in children with bacterial infections (P < .001). MxA cutoff of 101 µg/L differentiated between viral and bacterial infections with 92% sensitivity and 91% specificity.
Conclusions
POC MxA measurement demonstrated acceptable analytical accuracy compared to the reference method, and good diagnostic accuracy as a biomarker for viral infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Paediatrics and Adolescent Medicine, Turku University Hospital and University of Turku.
- InFLAMES Research Flagship Center, University of Turku.
- Institute of Biomedicine, University of Turku and Department of Clinical Microbiology, Turku University Hospital, Turku, Finland.
ORCID-Profile: Ruut Piri, Lauri Ivaska, Ilkka Julkunen, Ville Peltola, Matti Waris
Förderung
- University of Turku
- Foundation for Pediatric Research
- Maud Kuistila Memorial Foundation
- Päivikki and Sakari Sohlberg Foundation
- Labmaster Ltd
Zitieren
APA
Piri, R., Ivaska, L., Kujari, A. M., Julkunen, I., Peltola, V., & Waris, M. (2024). Evaluation of a Novel Point-of-Care Blood Myxovirus Resistance Protein A Measurement for the Detection of Viral Infection at the Pediatric Emergency Department. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiae367
Vancouver
Piri R, Ivaska L, Kujari AM, Julkunen I, Peltola V, Waris M. Evaluation of a Novel Point-of-Care Blood Myxovirus Resistance Protein A Measurement for the Detection of Viral Infection at the Pediatric Emergency Department. The Journal of Infectious Diseases. 2024. doi:10.1093/infdis/jiae367
BibTeX
@article{Piri2024,
author = {Piri, Ruut and Ivaska, Lauri and Kujari, Anna-Maija and Julkunen, Ilkka and Peltola, Ville and Waris, Matti},
title = {Evaluation of a Novel Point-of-Care Blood Myxovirus Resistance Protein A Measurement for the Detection of Viral Infection at the Pediatric Emergency Department},
journal = {The Journal of Infectious Diseases},
year = {2024},
doi = {10.1093/infdis/jiae367}
}
EUVIMED